Emmaus Life Sciences, Inc. Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Emmaus Life Sciences, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Emmaus Life Sciences, Inc. Return On Assets for the quarter ending September 30, 2024 was -11.9 %, a 21.8% decline year-over-year.
  • Emmaus Life Sciences, Inc. annual Return On Assets for 2023 was -8.21 %, a 63.7% increase from 2022.
  • Emmaus Life Sciences, Inc. annual Return On Assets for 2022 was -22.6 %, a 14.1% increase from 2021.
  • Emmaus Life Sciences, Inc. annual Return On Assets for 2021 was -26.3 %, a 1275% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -11.9 -2.12 -21.8% Jul 1, 2024 Sep 30, 2024
Q2 2024 -15.2 -4.26 -38.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -11.4 +15.7 +57.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -8.21 +14.4 +63.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 -9.73 +26.3 +73% Jul 1, 2023 Sep 30, 2023
Q2 2023 -11 +27.2 +71.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -27.1 -11.4 -72.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -22.6 +3.71 +14.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -36 -20.8 -136% Jul 1, 2022 Sep 30, 2022
Q2 2022 -38.2 -37.2 -3702% Apr 1, 2022 Jun 30, 2022
Q1 2022 -15.7 +5.48 +25.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -26.3 -28.6 -1275% Oct 1, 2021 Dec 31, 2021
Q3 2021 -15.3 -15.6 -5368% Jul 1, 2021 Sep 30, 2021
Q2 2021 -1 +38.7 +97.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 -21.1 +30.7 +59.2% Jan 1, 2021 Mar 31, 2021
Q4 2020 2.24 +89.4 Oct 1, 2020 Dec 31, 2020
Q3 2020 0.29 +83.7 Jul 1, 2020 Sep 30, 2020
Q2 2020 -39.7 +2.84 +6.68% Apr 1, 2020 Jun 30, 2020
Q1 2020 -51.8 +82.6 +61.4% Jan 1, 2020 Mar 31, 2020
Q4 2019 -87.2 +81.1 +48.2% Oct 1, 2019 Dec 31, 2019
Q3 2019 -83.4 +720 +89.6% Jul 1, 2019 Sep 30, 2019
Q2 2019 -42.5 +1.07K +96.2% Apr 1, 2019 Jun 30, 2019
Q1 2019 -134 +99.4 +42.5% Jan 1, 2019 Mar 31, 2019
Q4 2018 -168 +68.1 +28.8% Oct 1, 2018 Dec 31, 2018
Q3 2018 -804 -557 -226% Jul 1, 2018 Sep 30, 2018
Q2 2018 -1.11K -744 -203% Apr 1, 2018 Jun 30, 2018
Q1 2018 -234 +152 +39.3% Jan 1, 2018 Mar 31, 2018
Q4 2017 -236 +192 +44.9% Oct 1, 2017 Dec 31, 2017
Q3 2017 -247 +601 +70.9% Jul 1, 2017 Sep 30, 2017
Q2 2017 -367 +503 +57.8% Apr 1, 2017 Jun 30, 2017
Q1 2017 -385 +506 +56.8% Jan 1, 2017 Mar 31, 2017
Q4 2016 -429 +645 +60.1% Oct 1, 2016 Dec 31, 2016
Q3 2016 -848 -97.3 -13% Jul 1, 2016 Sep 30, 2016
Q2 2016 -871 -412 -90% Apr 1, 2016 Jun 30, 2016
Q1 2016 -891 -342 -62.2% Jan 1, 2016 Mar 31, 2016
Q4 2015 -1.07K -579 -117% Oct 1, 2015 Dec 31, 2015
Q3 2015 -751 -418 -126% Jul 1, 2015 Sep 30, 2015
Q2 2015 -458 +629 +57.8% Apr 1, 2015 Jun 30, 2015
Q1 2015 -550 +393 +41.7% Jan 1, 2015 Mar 31, 2015
Q4 2014 -496 +519 +51.1% Oct 1, 2014 Dec 31, 2014
Q3 2014 -332 +752 +69.4% Jul 1, 2014 Sep 30, 2014
Q2 2014 -1.09K -1.13K -2915% Apr 1, 2014 Jun 30, 2014
Q1 2014 -943 -1.93K -195% Jan 1, 2014 Mar 31, 2014
Q4 2013 -1.01K -672 -196% Oct 1, 2013 Dec 31, 2013
Q3 2013 -1.08K -161 -17.5% Jul 1, 2013 Sep 30, 2013
Q2 2013 38.6 +2.41K Apr 1, 2013 Jun 30, 2013
Q1 2013 992 +2.78K Jan 1, 2013 Mar 31, 2013
Q4 2012 -343 Oct 1, 2012 Dec 31, 2012
Q3 2012 -922 Jul 1, 2012 Sep 30, 2012
Q2 2012 -2.37K Apr 1, 2012 Jun 30, 2012
Q1 2012 -1.79K Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.